Cargando…

Fatty Acids, Obesity and Insulin Resistance

OBJECTIVE: Although elevated free fatty acid (FFA) levels in obesity have been considered to be of importance for insulin resistance, a recent meta-analysis suggested normal FFA levels in obese subjects. We investigated fasting circulating FFA and glycerol levels in a large cohort of non-obese and o...

Descripción completa

Detalles Bibliográficos
Autores principales: Arner, Peter, Rydén, Mikael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger GmbH 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644864/
https://www.ncbi.nlm.nih.gov/pubmed/25895754
http://dx.doi.org/10.1159/000381224
_version_ 1783271809567686656
author Arner, Peter
Rydén, Mikael
author_facet Arner, Peter
Rydén, Mikael
author_sort Arner, Peter
collection PubMed
description OBJECTIVE: Although elevated free fatty acid (FFA) levels in obesity have been considered to be of importance for insulin resistance, a recent meta-analysis suggested normal FFA levels in obese subjects. We investigated fasting circulating FFA and glycerol levels in a large cohort of non-obese and obese subjects. METHODS: Subjects recruited for a study on obesity genetics were investigated in the morning after an overnight fast (n = 3,888). Serum FFA (n = 3,306), plasma glycerol (n = 3,776), and insulin sensitivity index (HOMA-IR,n = 3,469) were determined. Obesity was defined as BMI ≥ 30 kg/m(2) and insulin resistance as HOMA-IR ≥ 2.21. RESULTS: In obese subjects, circulating FFA and glycerol levels were higher than in non-obese individuals (by 26% and 47%, respectively; both p < 0.0001). Similar results were obtained if only men, women or medication-free subjects were investigated. Insulin resistance and type 2 diabetes were associated with a further minor increase in FFA/glycerol among obese subjects. When comparing insulin-sensitive non-obese with insulin-sensitive or -resistant obese individuals, FFA and glycerol were 21-29% and 43-49% higher in obese individuals, respectively. CONCLUSION: Circulating FFA and glycerol levels are markedly elevated in obesity but only marginally influenced by insulin resistance and type 2 diabetes. Whether these differences persist during diurnal variations in circulating FFA/glycerol, remains to be established.
format Online
Article
Text
id pubmed-5644864
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher S. Karger GmbH
record_format MEDLINE/PubMed
spelling pubmed-56448642017-12-04 Fatty Acids, Obesity and Insulin Resistance Arner, Peter Rydén, Mikael Obes Facts Original Article OBJECTIVE: Although elevated free fatty acid (FFA) levels in obesity have been considered to be of importance for insulin resistance, a recent meta-analysis suggested normal FFA levels in obese subjects. We investigated fasting circulating FFA and glycerol levels in a large cohort of non-obese and obese subjects. METHODS: Subjects recruited for a study on obesity genetics were investigated in the morning after an overnight fast (n = 3,888). Serum FFA (n = 3,306), plasma glycerol (n = 3,776), and insulin sensitivity index (HOMA-IR,n = 3,469) were determined. Obesity was defined as BMI ≥ 30 kg/m(2) and insulin resistance as HOMA-IR ≥ 2.21. RESULTS: In obese subjects, circulating FFA and glycerol levels were higher than in non-obese individuals (by 26% and 47%, respectively; both p < 0.0001). Similar results were obtained if only men, women or medication-free subjects were investigated. Insulin resistance and type 2 diabetes were associated with a further minor increase in FFA/glycerol among obese subjects. When comparing insulin-sensitive non-obese with insulin-sensitive or -resistant obese individuals, FFA and glycerol were 21-29% and 43-49% higher in obese individuals, respectively. CONCLUSION: Circulating FFA and glycerol levels are markedly elevated in obesity but only marginally influenced by insulin resistance and type 2 diabetes. Whether these differences persist during diurnal variations in circulating FFA/glycerol, remains to be established. S. Karger GmbH 2015-04 2015-04-15 /pmc/articles/PMC5644864/ /pubmed/25895754 http://dx.doi.org/10.1159/000381224 Text en Copyright © 2015 by S. Karger GmbH, Freiburg http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable tothe online version of the article only. Distribution permitted for non-commercial purposes only.
spellingShingle Original Article
Arner, Peter
Rydén, Mikael
Fatty Acids, Obesity and Insulin Resistance
title Fatty Acids, Obesity and Insulin Resistance
title_full Fatty Acids, Obesity and Insulin Resistance
title_fullStr Fatty Acids, Obesity and Insulin Resistance
title_full_unstemmed Fatty Acids, Obesity and Insulin Resistance
title_short Fatty Acids, Obesity and Insulin Resistance
title_sort fatty acids, obesity and insulin resistance
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644864/
https://www.ncbi.nlm.nih.gov/pubmed/25895754
http://dx.doi.org/10.1159/000381224
work_keys_str_mv AT arnerpeter fattyacidsobesityandinsulinresistance
AT rydenmikael fattyacidsobesityandinsulinresistance